Hoeft, K.* ; Koch, L.* ; Ziegler, S.* ; Zhang, L.* ; Luetke, S.* ; Tanzer, M.C.* ; Mohanta, D.* ; Schumacher, D.* ; Schreibing, F.* ; Long, Q.* ; Kim, H.* ; Klinkhammer, B.M.* ; Schikarski, C.* ; Maryam, S.* ; Baens, M.* ; Hermann, J.* ; Krieg, S.* ; Peisker, F.* ; De Laporte, L.* ; Schaefer, G.J.L.* ; Menzel, S.* ; Jankowski, J.* ; Humphreys, B.D.* ; Wahida, A. ; Schneider, R.K.* ; Versele, M.* ; Boor, P.* ; Mann, M.* ; Sengle, G.* ; Hayat, S.* ; Kramann, R.*
ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts.
J. Clin. Invest. 134:e170246 (2024)
Fibrosis represents the uncontrolled replacement of parenchymal tissue with extracellular matrix (ECM) produced by myofibroblasts. While genetic fate-tracing and single-cell RNA-Seq technologies have helped elucidate fibroblast heterogeneity and ontogeny beyond fibroblast to myofibroblast differentiation, newly identified fibroblast populations remain ill defined, with respect to both the molecular cues driving their differentiation and their subsequent role in fibrosis. Using an unbiased approach, we identified the metalloprotease ADAMTS12 as a fibroblast-specific gene that is strongly upregulated during active fibrogenesis in humans and mice. Functional in vivo KO studies in mice confirmed that Adamts12 was critical during fibrogenesis in both heart and kidney. Mechanistically, using a combination of spatial transcriptomics and expression of catalytically active or inactive ADAMTS12, we demonstrated that the active protease of ADAMTS12 shaped ECM composition and cleaved hemicentin 1 (HMCN1) to enable the activation and migration of a distinct injury-responsive fibroblast subset defined by aberrant high JAK/STAT signaling.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cardiology ; Fibrosis ; Nephrology; Pathway Activation; Cells; Contributes; Growth; Image
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
0021-9738
e-ISSN
1558-8238
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 134,
Heft: 18,
Seiten: ,
Artikelnummer: e170246
Supplement: ,
Reihe
Verlag
American Society of Clinical Investigation
Verlagsort
2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-506900-001
Förderungen
Max Planck Society for the Advancement of Science
German Society for Cardiology Otto-Hess MD
German Research Foundation (DFG)
Europe-an Research Council
Else Kroener Fresenius Foundation (EKFS)
BMBF
BMBF consortia CureFib
DFG
European Research Council
Federal Ministry of Education and Research (BMBF)
German Society of Internal Medicine Peter Scriba
Copyright
Erfassungsdatum
2024-10-28